Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol

(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol

(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol structure

(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol 

structure
  • CAS No:

    14198-28-8

  • Formula:

    C17H23NO

  • Chemical Name:

    (2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol

  • Synonyms:

    2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-,(2R,6R,11R)-;2,6-Methano-3-benzazocin-8-ol,3-allyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-,cis-(-)-;2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-,[2R-(2α,6α,11R*)]-;2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-,(2R,6R,11R)-;(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol;(-)-N-Allylnormetazocine;(-)-SKF 10047;l-SKF 10047;(-)-Alazocine;l-N-Allylnormetazocine;(-)-ANMC;N-Allylnorcyclazocine;7619-35-4;58640-81-6;802564-00-7

  • Categories:

    Analytical Chemistry  >  Standard

(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol Basic Attributes

293.83

257.37

K9DGJ27JKH

Characteristics

23.47000

3.04030

white solid

1.055±0.06 g/cm3(Predicted)

138-139 °C

373.6±42.0 °C(Predicted)

169.9ºC

1.559

H2O: soluble

Safety Information

NONH for all modes of transport

3

20/21/22

36

Xn

P280

H302-H312-H332

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

2'-hydroxy-5,9-dimethyl-2-allyl-6,7-benzomorphan

Computed Properties

Molecular Weight:257.37
XLogP3:2.5
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:2
Exact Mass:257.177964357
Monoisotopic Mass:257.177964357
Topological Polar Surface Area:23.5
Heavy Atom Count:19
Complexity:355
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.